Evidence of Type II Pneumocyte Apoptosis in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IFP)/usual Interstitial Pneumonia (UIP)

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2001 Feb 24

PMID 11215282

Citations 94

Authors

J V Barbas-Filho

M A Ferreira

A Sesso

R A Kairalla

C R Carvalho

V L Capelozzi

Affiliations

Soon will be listed here.

Abstract

Background/aims: The pathogenesis of idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia (UIP), a chronic and incurable human respiratory disease, is not well established. This study was designed to investigate whether the apoptosis of type II pneumocytes could be the precipitating factor in the pathogenesis of IPF.

Methods: Nineteen specimens obtained by retrospective review of the medical and pathological records of 55 patients with IPF, four normal subjects, and 10 disease control lungs were analysed. The selected specimens had normal alveoli with intervening patchy scarring of the lung parenchyma, fulfilling the pathological criteria for UIP. To identify individual cells undergoing apoptosis in the normal alveoli, electron microscopy and in situ end labelling of fragmented DNA were performed on paraffin was embedded sections using digoxigenin-11-dUTP and the enzyme terminal deoxynucleotidyl transferase.

Results: Apoptosis was detected in the normal alveoli of 17 of the 19 patients with IPF/UIP and was absent in the controls. Electron microscopy demonstrated apoptotic changes in type II pneumocytes. These results indicate that apoptotic type II pneumocyte death occurs in normal alveoli of IPF/UIP and could be the principal cause of several events that account for the histological, clinical, and functional alterations seen in IPF/UIP.

Conclusions: In conclusion, numerous type II pneumocytes from the normal alveoli of most patients with IPF/UIP actively undergo programmed cell death. This finding may shed new light on the pathogenesis of this disease, with implications mainly for the treatment of affected patients.

Citing Articles

Aufy M, Abd-Elkareem M, Mustafic M, Abdel-Maksoud M, Hakamy A, Baresova V PLoS One. 2024; 19(12):e0311760.

PMID: 39705219 PMC: 11661583. DOI: 10.1371/journal.pone.0311760.

Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic.

Yuan D, Bao Y, El-Hashash A Am J Stem Cells. 2024; 13(2):37-58.

PMID: 38765802 PMC: 11101986. DOI: 10.62347/JAWM2040.

Mitochondrial Dysfunction in Lung Resident Mesenchymal Stem Cells from Idiopathic Pulmonary Fibrosis Patients.

Mercader-Barcelo J, Martin-Medina A, Truyols-Vives J, Escarrer-Garau G, Elowsson L, Montes-Worboys A Cells. 2023; 12(16).

PMID: 37626894 PMC: 10453747. DOI: 10.3390/cells12162084.

Oxymatrine inhibits TGF‑β1‑mediated mitochondrial apoptotic signaling in alveolar epithelial cells via activation of PI3K/AKT signaling.

Feng T, Duan R, Zheng P, Qiu J, Li Q, Li W Exp Ther Med. 2023; 25(5):198.

PMID: 37090069 PMC: 10119625. DOI: 10.3892/etm.2023.11897.

Neutrophil extracellular traps and pulmonary fibrosis: an update.

Yan S, Li M, Liu B, Ma Z, Yang Q J Inflamm (Lond). 2023; 20(1):2.

PMID: 36658568 PMC: 9851107. DOI: 10.1186/s12950-023-00329-y.

References

Wyllie A, KERR J, Currie A . Cell death: the significance of apoptosis. Int Rev Cytol. 1980; 68:251-306. DOI: 10.1016/s0074-7696(08)62312-8. View

Fulmer J, Bienkowski R, Cowan M, Breul S, Bradley K, Ferrans V . Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1980; 122(2):289-301. DOI: 10.1164/arrd.1980.122.2.289. View

Wilson T, Bachofen H . A model for mechanical structure of the alveolar duct. J Appl Physiol Respir Environ Exerc Physiol. 1982; 52(4):1064-70. DOI: 10.1152/jappl.1982.52.4.1064. View

Goldstein R, Polgar P . The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem. 1982; 257(15):8630-3. View

Crapo J, Barry B, Gehr P, Bachofen M, Weibel E . Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 1982; 126(2):332-7. DOI: 10.1164/arrd.1982.126.2.332. View

Crystal R, Bitterman P, Rennard S, HANCE A, Keogh B . Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med. 1984; 310(3):154-66. DOI: 10.1056/NEJM198401193100304. View

Katzenstein A . Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study. Hum Pathol. 1985; 16(10):1015-24. DOI: 10.1016/s0046-8177(85)80279-3. View

Basset F, Ferrans V, Soler P, Takemura T, Fukuda Y, Crystal R . Intraluminal fibrosis in interstitial lung disorders. Am J Pathol. 1986; 122(3):443-61. PMC: 1888228. View

Katzenstein A, Myers J, Mazur M . Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol. 1986; 10(4):256-67. View

10.

Chauncey J, Peters-Golden M, Simon R . Arachidonic acid metabolism by rat alveolar epithelial cells. Lab Invest. 1988; 58(2):133-40. View

11.

Adamson I, Young L, BOWDEN D . Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol. 1988; 130(2):377-83. PMC: 1880524. View

12.

Robinson P, Watters L, King T, Mason R . Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis. 1988; 137(3):585-91. DOI: 10.1164/ajrccm/137.3.585. View

13.

Gundersen H, Bendtsen T, Korbo L, Marcussen N, Moller A, Nielsen K . Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 1988; 96(5):379-94. DOI: 10.1111/j.1699-0463.1988.tb05320.x. View

14.

Walker N, Harmon B, Gobe G, KERR J . Patterns of cell death. Methods Achiev Exp Pathol. 1988; 13:18-54. View

15.

Myers J, Katzenstein A . Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. Chest. 1988; 94(6):1309-11. DOI: 10.1378/chest.94.6.1309. View

16.

Burkhardt A . Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis. 1989; 140(2):513-24. DOI: 10.1164/ajrccm/140.2.513. View

17.

CHERNIACK R, Crystal R, Kalica A . NHLBI Workshop summary. Current concepts in idiopathic pulmonary fibrosis: a road map for the future. Am Rev Respir Dis. 1991; 143(3):680-3. DOI: 10.1164/ajrccm/143.3.680. View

18.

Gavrieli Y, Sherman Y, Ben-Sasson S . Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992; 119(3):493-501. PMC: 2289665. DOI: 10.1083/jcb.119.3.493. View

19.

Wijsman J, Jonker R, Keijzer R, van de Velde C, Cornelisse C, Van Dierendonck J . A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 1993; 41(1):7-12. DOI: 10.1177/41.1.7678025. View

20.

Williams G, Smith C . Molecular regulation of apoptosis: genetic controls on cell death. Cell. 1993; 74(5):777-9. DOI: 10.1016/0092-8674(93)90457-2. View